Medicare Enrolled
Dr. Marc Plawker, M.D.
Optician · Staten Island, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Plawker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Plawker?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Plawker
Dr. Marc Plawker is an optician specialist in Staten Island, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Plawker performed 76,664 Medicare services across 6,155 unique beneficiaries.
Between the years covered by Open Payments, Dr. Plawker received a total of $2,621 from 38 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Plawker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in NY
$2,621 industry payments
Medicare Practice Summary
Medicare Utilization ↗76,664
Medicare services
Top 0% in NY for optician
6,155
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,833 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
59,326 | $0 | $1 |
| Injection, degarelix, 1 mg | 2,640 | $3 | $9 |
| Denosumab injection (Prolia/Xgeva) | 1,981 | $19 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,946 | $79 | $150 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,620 | $10 | $95 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
1,242 | $31 | $175 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
1,235 | $40 | $160 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
943 | $113 | $225 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
800 | $2 | $15 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
794 | $5 | $30 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
504 | $0 | $150 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
495 | $96 | $750 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
374 | $283 | $1,504 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 294 | $136 | $750 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
288 | $13 | $50 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
251 | $51 | $1,200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
229 | $142 | $300 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
170 | $22 | $50 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
150 | $6 | $600 |
| Electrical stimulation therapy, per 15 minutes Application of electrical stimulation to the body with a therapist present. The service is billed for each 15-minute increment of treatment. |
150 | $12 | $130 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
140 | $125 | $700 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
116 | $33 | $130 |
| Assessment of muscle signal of pelvic nerves This procedure evaluates the electrical activity or signal of muscles innervated by the pelvic nerves. It is used to assess the functional status of these nerves and the muscles they control. |
110 | $262 | $1,000 |
| Injection, garamycin, gentamicin, up to 80 mg | 106 | $2 | $125 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
84 | $234 | $1,200 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
84 | $32 | $150 |
| Rectal sensitivity and function study A test to evaluate the sensitivity and functional performance of the rectum. |
69 | $265 | $1,500 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
55 | $56 | $750 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
51 | $188 | $1,010 |
| Functional capacity test, per 15 minutes A test or measurement to assess functional capacity. The service is billed for each 15-minute increment. |
49 | $31 | $1,500 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
48 | $355 | $4,542 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
45 | $0 | $25 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
39 | $318 | $3,000 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
39 | $169 | $1,800 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
38 | $764 | $7,000 |
| Simple measurement of urine flow pressure in bladder A test that measures the pressure of urine flow within the bladder. This procedure assesses bladder function by recording pressure changes during urination. |
30 | $209 | $2,500 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
29 | $55 | $700 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
27 | $733 | $7,000 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
22 | $234 | $1,500 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
21 | $126 | $500 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
17 | $36 | $75 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
13 | $45 | $750 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
87.9% medium
12.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,621
Total received (2018-2024)
Avg $374/year across 7 years
Top 34% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,505 (95.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$117 (4.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$283
2023
$333
2022
$468
2021
$473
2020
$390
2019
$369
2018
$305
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tolmar, Inc.
$110
Ferring Pharmaceuticals Inc.
$38
Janssen Biotech, Inc.
$30
Sumitomo Pharma America, Inc.
$18
Verity Pharmaceuticals Inc.
$16
180 Medical, Inc.
$14
BIOPROTECT MEDICAL, INC.
$14
ABBVIE INC.
$14
Astellas Pharma US Inc
$14
Bayer Healthcare Pharmaceuticals Inc.
$13
Top 3 companies account for 63.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$476
Janssen Biotech, Inc.
$430
UROVANT SCIENCES INC
$157
Endo Pharmaceuticals Inc.
$153
180 Medical, Inc.
$138
Amgen Inc.
$125
Tolmar, Inc.
$110
Bayer HealthCare Pharmaceuticals Inc.
$92
ABBVIE INC.
$87
Boston Scientific Corporation
$70
Verity Pharmaceuticals Inc.
$50
Myovant Sciences Inc.
$47
Dendreon Pharmaceuticals LLC
$46
Bayer Healthcare Pharmaceuticals Inc.
$44
Progenics Pharmaceuticals, Inc.
$42
Sumitomo Pharma America, Inc.
$41
Ferring Pharmaceuticals Inc.
$38
AbbVie Inc.
$37
Teleflex LLC
$35
Merck Sharp & Dohme LLC
$35
Mission Pharmacal Company
$33
BOSTON SCIENTIFIC CORPORATION
$32
DENTSPLY IH Inc.
$32
AstraZeneca Pharmaceuticals LP
$28
Merck Sharp & Dohme Corporation
$25
Hollister Incorporated
$25
Allergan Inc.
$24
Palette Life Sciences, Inc.
$21
Blue Earth Diagnostics Limited
$20
Antares Pharma, Inc.
$18
PROCEPT BioRobotics Corporation
$16
PFIZER INC.
$16
Laborie Medical Technologies Corp.
$16
BIOPROTECT MEDICAL, INC.
$14
Allergan, Inc.
$14
Avadel Specialty Pharmaceuticals, LLC
$12
AbbVie, Inc.
$12
Rochester Medical Corporation
$11
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AVEED · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · EDEX · ELIGARD · ERLEADA · EVENITY · Erleada · GEMTESA · GENERAL THERAPIES · GENERAL - THERAPIES · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PROVENGE · PYLARIFY · Prolia · SPACEOAR VUE · SpaceOAR VUE System - 10mL · Trelstar · UROLIFT · Uribel · UroLift System · Urocit-K · VaPro Pocket · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
12,677
Per 100K population
2572.8
County median income
$98,290
Nearest hospital
STATEN ISLAND UNIVERSITY HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Plawker is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Plawker experienced with testosterone injection?
Based on Medicare claims data, Dr. Plawker performed 59,326 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Plawker receive payments from pharmaceutical companies?
Yes. Dr. Plawker received a total of $2,621 from 38 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Plawker's costs compare to other opticians in Staten Island?
Dr. Plawker's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Plawker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Staten Island
Browse opticians in Staten Island ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
UROVANT SCIENCES INC Payments to Doctors
See all physicians who received payments from UROVANT SCIENCES INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology